Home
Public services
Dashboard
Curated content

Companies
Job board
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities

More organizations

Matching tool
Investment heatmap
Themes

Powered by

dealroom.co

Contact
FAQ
Privacy

Companies
Alnylam Pharmaceuticals
Team
Team

Alnylam Pharmaceuticals

Develops novel therapeutics-based RNAi and provides overviews of recent drug development programs. Learn more

Launch date

2002

Employees

1001-5000 people

Market cap

CAD45.8b

Enterprise valuation

CAD44.0b (Public information from Sep 2024)

Share price

$276.32999 ALNY

Cambridge Massachusetts (HQ)

http://alnylam.com

https://twitter.com/alnylam https://www.linkedin.com/company/alnylam-pharmaceuticals alnylampharma

B2C
health
biotechnology

hard tech
biotechnology
biotech and pharma
verified unicorns and $1b exits
post ipo $1b

Authorizing premium user...